The Seeds on Your Shelf May Be Fighting Cancer at a Cellular Level — Here’s What the Science Shows
A comprehensive new review from researchers across Pakistan, Ireland, China, and Saudi Arabia synthesises the latest evidence on how seed-derived plant compounds neutralise oxidative stress, block cancer growth, and how cutting-edge nanotechnology and AI are unlocking their full therapeutic potential.
Flaxseeds. Pumpkin seeds. Chia seeds. Sesame. Hemp. Sunflower. These foods sit in kitchen cupboards around the world, consumed daily without much thought for their biochemistry. But inside each seed lies a dense pharmacopoeia of bioactive compounds — quercetin, lignans, sulforaphane, sesamin, terpenoids — that plant evolution has spent millions of years refining as chemical armour. A sweeping new review now asks: can that armour protect us too?
Published in Cancer Biotherapy and Radiopharmaceuticals, this review synthesises evidence from in vitro, in vivo, and clinical studies to explore how phytochemicals derived from plant seeds modulate oxidative stress, inhibit cancer cell growth, and interact with key molecular pathways — and how nanotechnology and AI-driven tools are overcoming the key limitation that has historically held these compounds back: getting them to where they need to go in the body.
The Problem: Oxidative Stress and Why It Matters
Every cell in the body produces reactive oxygen species (ROS) — unstable molecules generated as a byproduct of normal metabolism. Under healthy conditions, the body’s antioxidant defence systems keep ROS in check. But when the balance tips — from smoking, pollution, excessive alcohol consumption, chronic inflammation, or simply the wear of aging — oxidative stress results.
Oxidative stress is not a minor inconvenience. When ROS overwhelm cellular defences, they damage DNA, RNA, proteins, and lipid membranes. This molecular damage accumulates over time and contributes directly to the development of cancer, type 2 diabetes, cardiovascular disease, and neurodegenerative conditions including Alzheimer’s and Parkinson’s disease.
Think of oxidative stress as cellular rust. When the body produces more damaging free radicals (ROS) than its antioxidant systems can neutralise, those radicals attack DNA, proteins, and cell membranes. Over time, this molecular damage accumulates and drives the development of cancer and chronic disease. Phytochemicals are, in essence, the body’s borrowed rust inhibitors — borrowed from plants that evolved them for their own protection.
What Are Phytochemicals — and Why Seeds?
Phytochemicals are bioactive compounds that plants produce as secondary metabolites — chemical tools that protect plants against insects, pathogens, UV radiation, and environmental stress. They are not essential nutrients in the classical sense, but their effect on human health is far from trivial. Decades of epidemiological and experimental research consistently link plant-rich diets with reduced risk of cancer, cardiovascular disease, and diabetes.
Seeds are a particularly concentrated source. Unlike fruit flesh, which is designed to be eaten and dispersed, seeds need to survive — they are protected by tough coatings and packed with bioactive compounds that serve as the plant’s most essential chemical arsenal. This makes seeds gram-for-gram among the most phytochemically dense foods available.
The Major Classes of Seed Phytochemicals
The largest and most diverse class — includes flavonoids, phenolic acids, lignans, and stilbenes. Powerful antioxidants that directly scavenge ROS by donating hydrogen atoms or electrons
Over 36,000 distinct structures known. Include D-limonene and beta-carotene. Exhibit anticancer, antiviral, antifungal, and neuroprotective activity. Disrupt microbial membranes and inhibit carcinogen-DNA interactions
Includes sulforaphane and glucosinolates. Strongly anticancer — suppress tumour angiogenesis and metastasis, activate detoxifying enzymes, and induce apoptosis in cancer cells
Phytoestrogens with antioxidant and oestrogen-modulating properties. Secoisolariciresinol diglucoside (SDG) in flaxseed has demonstrated significant breast cancer-suppressing effects in experimental models
The green pigments of plants. Scavenge free radicals, inhibit DNA adduct formation, and are used as photosensitisers in photodynamic cancer therapy. Antimutagenic and anticancer properties supported by experimental data
Cholesterol-like plant compounds with immunomodulatory, anti-inflammatory, and anticancer properties. Beta-sitosterol has demonstrated activity against prostate cancer cell lines
The Four Lines of Defence
One of the most useful frameworks in this review is the concept of phytochemicals operating across four sequential lines of cellular defence against oxidative damage:
The Key Molecular Pathway: Nrf2/Keap1
Much of the review focuses on a critical cellular signalling pathway called Nrf2/Keap1, which acts as the master regulator of the body’s antioxidant gene expression. Under normal conditions, Nrf2 is kept inactive in the cytoplasm. But when oxidative stress occurs — or when phytochemicals trigger it beneficially — the pathway is activated, Nrf2 moves into the cell nucleus, and a cascade of antioxidant and detoxifying genes switches on.
Multiple seed phytochemicals have been shown to activate this pathway: curcumin, sulforaphane, sesamin, fennel seed extracts, and flaxseed lignans all demonstrate Nrf2 activation in experimental models. Molecular docking studies have even predicted sesamin binding to Keap1 with a strong affinity of −8.4 kcal/mol, supporting its potential as a chemopreventive agent.
Seed by Seed: What the Evidence Shows
Widely called a “superfood,” flaxseeds contain one of the most studied anticancer compounds in plant nutrition: secoisolariciresinol diglucoside (SDG), a lignan with chemopreventive properties. In vitro studies show apoptosis induction in glioblastoma, breast cancer, ovarian cancer, cervical, colon, and leukemia cell lines. Linseed proteins have demonstrated cytotoxicity against multiple cancer types.
Chia seeds (Salvia hispanica L.) are exceptionally rich in omega-3 fatty acids — providing around 68% of their oil as ALA — and potent polyphenolic antioxidants. Animal studies show promising antilung cancer activity, with oral chia seed extract significantly reducing lung cancer biomarkers in NNK-induced rat models over 5 months. Nanoencapsulated chia seed extract (PLGA-PEG nanoparticles) has been investigated as a potential adjuvant treatment for breast cancer cells.
Sesame seeds contain a remarkable array of lignans — sesamin, sesamolin, and sesaminol — that have demonstrated anticancer activity across multiple cancer types including colorectal, esophageal, nasopharyngeal, and leukemia. Sesamin inhibits NF-κB signalling (a key inflammation and tumour growth pathway), suppresses angiogenesis in colorectal cancer, and induces autophagy and apoptosis in nasopharyngeal carcinoma models. Black sesame seeds showed particularly strong antiprostate cancer activity via molecular docking, outperforming the conventional drug 5-fluorouracil in binding affinity to cancer-associated proteins.
Pumpkin seeds are nutritionally dense — rich in dietary fibre, protein, PUFAs, iron, magnesium, zinc, and copper — and have been used in traditional medicine for their antidiabetic, antioxidant, and antiparasitic properties. Biogenically synthesised copper-based nanoparticles (CMBNPs) derived from pumpkin seed extract showed dose-dependent cytotoxicity against colon cancer cells and caused significant DNA damage in cancer cell lines. Aqueous extracts have demonstrated strong antioxidant and anticancer activity in cell and animal studies.
Hemp seeds (Cannabis sativa L.) are gaining recognition for their antioxidant and anticancer potential, driven by a unique combination of cannabinoids, terpenes, and polyphenols. Hemp seed extracts have shown antiproliferative activity against leukemia and breast cancer cell lines, with different cultivar extracts showing varying intensity of activity. The compound N-trans-caffeoyltyramine is identified as a strong free radical scavenger. Hemp seeds show the highest total phenolic content among seeds studied, with outstanding radical scavenging activity.
The Bioavailability Problem — And How Nanotechnology Solves It
Here is the central challenge that has frustrated phytochemical researchers for decades. Many of these compounds — curcumin, resveratrol, quercetin, sulforaphane — demonstrate spectacular anticancer activity in laboratory settings. Then, in human studies, the results are far more modest. The reason is almost always the same: bioavailability.
When phytochemicals are consumed orally, they face a gauntlet of degradation — stomach acid, intestinal enzymes, liver metabolism, and active transport pumps that expel them from cells. By the time they reach target tissues, the concentration that remains may be far below what was effective in a test tube.
Nanotechnology is changing this equation fundamentally. By encapsulating phytochemicals in nanoscale carriers — liposomes, polymeric nanoparticles, micelles, nanoemulsions — researchers can protect bioactive compounds from early degradation, improve their solubility in water, extend their circulation time in the body, and direct them specifically toward tumour tissue.
| Phytochemical | Nanocarrier | Key Result |
|---|---|---|
| Curcumin | Galactosylated chitosan-coated PEG-PLGA nanoparticles | 5.4× increased oral bioavailability; 63% tumour volume reduction in hepatocellular carcinoma model |
| Sulforaphane | Self-assembled nanomicelles (25–50 nm) | Enhanced glioma cell death under sonodynamic therapy conditions |
| Resveratrol (grape seed) | Chitosan-folic acid surface-modified PLGA nanoparticles (~180 nm) | IC50 reduced from 52.7 to 21.9 μM — significantly higher cytotoxicity than free resveratrol in prostate cancer cells |
| Sulforaphane + Doxorubicin | Co-loaded liposomes (~125–150 nm) | 2× tumour inhibition vs doxorubicin alone; reduced required drug dose; protected organs from systemic toxicity |
| Sesamin | Self-nanoemulsifying drug delivery system (~66 nm) | 3× improvement in intestinal permeability in rat oral model |
| EGCG (green tea) | Gold nanoparticles (25 nm) | 52% reduction in metastatic progression in murine breast cancer model; NF-κB signalling inhibited |
AI and Omics: The Next Frontier
Beyond nanotechnology, the review highlights how artificial intelligence and omics technologies are transforming phytochemical research in ways that would have been impossible a decade ago.
- Molecular docking (AutoDock Vina, FlexX) — computationally predicts how phytochemicals bind to cancer-related proteins, identifying promising candidates before expensive lab work begins. Sesamin was predicted to bind Keap1 at −8.4 kcal/mol, supporting its Nrf2-activating role
- Machine learning QSAR models — Random Forest algorithms have achieved 0.89 prediction accuracy for antioxidant potential using 75 molecular descriptors, enabling rapid virtual screening of phytochemical libraries
- Graph neural networks (FP-GNN) — predict ADMET properties (absorption, distribution, metabolism, excretion, toxicity) of novel phytochemicals with greater accuracy than traditional methods
- Omics integration — genomics, metabolomics, proteomics, and transcriptomics are being used to understand how phytochemicals interact with disease pathways at the whole-system level, paving the way for personalised phytochemical nutrition
- MoCoP framework — Molecule-Morphology Contrastive Pretraining links molecular structures to cellular morphological effects, improving prediction of biological behaviour in complex living systems
From Lab to Life: Food and Pharmaceutical Applications
The practical applications of seed phytochemicals extend well beyond cancer therapy. The review documents a growing ecosystem of real-world applications:
What the Science Still Cannot Tell Us
The review is commendably honest about the considerable gap between laboratory excitement and clinical reality. Several important limitations run through almost all the evidence reviewed:
Most phytochemical studies use concentrations far higher than normal dietary intake. Animal metabolism differs significantly from human metabolism, meaning animal results often do not translate directly. Extraction methods, seed origin, processing, and study design vary enormously across studies, making comparisons difficult. Many flavonoids can switch from antioxidant to pro-oxidant at high doses. And human clinical trials — the gold standard — remain scarce, underpowered, or preliminary for most seed phytochemicals. The science is genuinely promising; it is not yet conclusive.
Key Takeaways from the Review
- Seeds are phytochemical powerhouses: Flaxseed, chia, sesame, pumpkin, hemp, and sunflower seeds each contain distinct bioactive compounds with demonstrated antioxidant and anticancer properties across multiple experimental models
- The Nrf2/Keap1 pathway is central: Multiple seed phytochemicals activate this master antioxidant regulator, switching on a battery of protective genes — making it a key target for cancer prevention research
- Bioavailability has been the historic bottleneck: Compounds that are brilliant in a test tube often fail to reach target tissues in sufficient concentrations. Nanotechnology — nanoparticles, liposomes, micelles, nanoemulsions — is providing the delivery infrastructure that phytochemicals have always needed
- The combination of phyto + nano is especially powerful: Co-loaded nanoparticles delivering sulforaphane alongside conventional chemotherapy drugs showed 2× greater tumour inhibition while allowing lower drug doses — a potentially transformative approach to reducing chemotherapy toxicity
- AI is accelerating discovery: Molecular docking, machine learning, and omics integration are compressing the timeline from plant compound to clinical candidate — and enabling personalised nutrition approaches based on individual genetic profiles
- Human trials are urgently needed: The overwhelming majority of compelling evidence comes from cell studies and animal models. Rigorous, well-powered human trials with standardised extraction methods and dose-response analyses must be the priority for the next decade of research
The humble seeds in your kitchen are doing extraordinary biochemistry. The science of harnessing that biochemistry at therapeutic scale — reliably, safely, and in forms the human body can actually absorb — is advancing faster than at any point in history. The next decade of research may finally close the gap between ancient dietary wisdom and modern clinical medicine.
